BB Biotech AG
BION
Clasificación en acciones
#4531
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Precio por acción
$60.49
Capitalización bursátil
$3.34B
Cambio (1 día)
-1.09%
Cambio (1 año)
23.62%
País
CH
Comercio BB Biotech AG (BION)
Categoría
Financial Services
Historial del precio de la acción de BB Biotech AG (BION)
Precio más alto de cierre: $63.78 el 2026-10-01
Precio más bajo de cierre: $15.30 el 2000-01-01
Precio más bajo de cierre: $15.30 el 2000-01-01
Historial del precio de la acción de BB Biotech AG desde 2000 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 6.35% |
| 2025 | 38.69% |
| 2024 | -11.18% |
| 2023 | -24.95% |
| 2022 | -25.80% |
| 2021 | 2.69% |
| 2020 | 17.40% |
| 2019 | 11.01% |
| 2018 | -6.61% |
| 2017 | 23.80% |
| 2016 | -7.89% |
| 2015 | 22.59% |
| 2014 | 52.76% |
| 2013 | 62.77% |
| 2012 | 49.65% |
| 2011 | 1.37% |
| 2010 | -14.60% |
| 2009 | 29.73% |
| 2008 | -26.26% |
| 2007 | 3.29% |
| 2006 | 23.76% |
| 2005 | 1.84% |
| 2004 | 19.32% |
| 2003 | 21.32% |
| 2002 | -43.88% |
| 2001 | -30.37% |
| 2000 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $1.15K | 1.58% |
US
|
|
| $40.94 | 23.79% |
SE
|
|
| $109.74 | -32.14% |
US
|
|
| $89.85 | -27.13% |
US
|
|
| $46.03 | -14.74% |
US
|
